摘要
目的探讨雷公藤红素、顺铂联合应用对C6胶质瘤细胞的抑制效果和凋亡机制。方法雷公藤红素、顺铂单独及联合用药作用于C6胶质瘤细胞,采用CCK-8法测定各组细胞的生长抑制率,流式细胞术检测细胞凋亡情况,酶联免疫吸附实验检测细胞凋亡相关蛋白Bcl-2、Bax、XIAP、NF-κB的表达水平变化。结果相对于雷公藤红素和顺铂分别单独用药,雷公藤红素能够协同顺铂显著抑制C6胶质瘤细胞地生长,抑制率达到(69.76±7.28)%(t=23.78,P〈0.01);雷公藤红素联合顺铂用药组凋亡率为(47.75±5.63)%高于雷公藤红素组、顺铂组;酶联免疫吸附实验结果表明,雷公藤红素联合顺铂组Bax蛋白表达量明显高于单独用药组(t=10.59,P〈0.01),Bcl-2蛋白表达量、XIAP、NF-kB蛋白表达量明显低于单独用药组(t=35.27,P〈0.01)。结论雷公藤红素联合顺铂抑制体外C6胶质瘤细胞的增殖,可能是通过上调Bax蛋白的表达、降低抗凋亡蛋白Bcl、抑制XIAP及NF-kB蛋白的表达进而诱导肿瘤细胞凋亡。
Objective To clarify the inhibitory effect of Tripterine combined with Cisp]atin on C6 glioma cells and its apoptosis mechanism. Methods C6 glioma cells were treated with Tripterine, Cisplatin, or Tripterine combined with Cisplatin. CCK-8 assay was used to detect the growth inhibition rate in each group. Flow cytometry analysis was used to test the cell apoptosis rate. The expressions of apoptosis-related proteins including Bcl-2, Bax, XIAP, NF-kB were analyzed by ELISA. Results Compared with Tripterine- or Cisplatin-treated group, the inhibition ratio of cell growth in Tripterine and Cisplatin combination group was (69.76±7.28) %, which could significantly inhibit the growth of C6 glioma cells(t= 23.78, P〈0.01). The apoptosis rate was significantly higher (47.75±5.63) %in combination group than in Tripterine or Cisplatin treated group. The results of ELISA showed that the expression of Bax was significantly higher and Bcl-2, XIAP, NF-κB were obviously lower in the combination group than in Tripterine or Cisplatin treated group (t= 35.27, P〈0.01). Conclusion The combination of Tripterine and Cisplatin significantly increases the inhibition rate on C6 glioma cells through upregulating Bax and inhibiting Bcl, XIAP and NF-kB to induce the apoptosis of C6 glioma cells.
出处
《中华老年医学杂志》
CAS
CSCD
北大核心
2016年第8期898-901,共4页
Chinese Journal of Geriatrics